phase readout
saveNCT06866548: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
ACTIVE_NOT_RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Shanghai Changzheng Hospital. Phase: EARLY_PHASE1. Conditions: mCRPC
view source ↗
comments(0)
5-min edit window · permanent after that